Abstract
Purpose
To compare the anti-inflammatory activity of preoperatively applied eyedrops, as determined by cytokine concentrations in aqueous humor collected during surgery in patients undergoing femtosecond laser–assisted cataract surgery.
Methods
A total of 120 patients undergoing femtosecond laser–assisted cataract surgery were randomly assigned to four groups of 30 patients each. Groups were administered 0.1% fluorometholone eyedrops, 0.45% ketorolac tromethamine eyedrops, both 0.1% fluorometholone and 0.45% ketorolac tromethamine eyedrops, or no eyedrops. Eyedrops were instilled 1 h, 20 min, and just before surgery. After anterior capsulotomy and nuclear fragmentation using a femtosecond laser, 0.1 cc aqueous humor was obtained using a needle and syringe. Cytokine and prostaglandin E2 (PGE2) concentrations were quantitatively determined.
Results
The 120 patients included 59 men and 61 women, of mean age 65.02 years. The mean interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) concentrations after treatment did not differ significantly in the four groups. The average interleukin-8 (IL-8) concentrations were significantly lower in the fluorometholone (4.80 pg/mL), ketorolac tromethamine (4.84 pg/mL), and fluorometholone + ketorolac tromethamine (4.68 pg/mL) groups than in the control group (6.83 pg/mL). Furthermore, the average PGE2 concentrations were significantly lower in the ketorolac tromethamine (270.04 pg/mL) and fluorometholone + ketorolac tromethamine (239.00 pg/mL) groups, but not in the fluorometholone (393.16 pg/mL) group, than in the control group (472.36 pg/mL).
Conclusion
Preoperative fluorometholone instillation reduced IL-8, and ketorolac tromethamine instillation reduced IL-8 and PGE2, in aqueous humor of patients undergoing femtosecond laser surgery, with the combination of both eyedrops being more effective than either alone.
Trial registration
KCT0005717
Similar content being viewed by others
Data availability
The data used to support the findings of this study are available from the corresponding author upon request.
Code availability
Not applicable.
References
Day AC, Burr JM, Bennett K, Dore CJ, Bunce C, Hunter R, Nanavaty MA, Balaggan KS, Wilkins MR, FACT trial group, (2020) Femtosecond laser-assisted cataract surgery compared with phacoemulsification cataract surgery: randomized noninferiority trial with 1-year outcomes. J Cataract Refract Surg 46:1360–1367
Jun JH, Yoo YS, Lim SA, Joo CK (2017) Effects of topical ketorolac tromethamine 0.45% on intraoperative miosis and prostaglandin E2 release during femtosecond laser-assisted cataract surgery. J Cataract Refract Surg 43:492–497
Wang L, Zhang Z, Koch DD, Jia Y, Cao W, Zhang S (2016) Anterior chamber interleukin 1 β, interleukin 6 and prostaglandin E2 in patients undergoing femtosecond laser-assisted cataract surgery. Br J Ophthalmol 100:579–582
Schultz T, Joachim SC, Kuehn M, Dick HB (2013) Changes in prostaglandin levels in patients undergoing femtosecond laser-assisted cataract surgery. J Refract Surg 29:742–747
Chen H, Lin H, Zheng D, Liu Y, Chen W, Liu Y (2015) Expression of cytokines, chemokines and growth factors in patients undergoing cataract surgery with femtosecond laser pretreatment. PLoS One 10:e0137227
Diakonis VF, Anagnostopoulos AG, Moutsiopoulou A, Yesilirmak N, Cabot F, Waren DP, O’Brien TP, Yoo SH, Weinstock RJ, Donaldson KE (2018) The effect of NSAID pretreatment on aqueous humor prostaglandin E2 concentration in eyes undergoing femtosecond laser-assisted capsulotomy. J Ophthalmol 2018:1891249
Schultz T, Joachim SC, Szuler M, Stellbogen M, Dick HB (2015) NSAID pretreatment inhibits prostaglandin release in femtosecond laser-assisted cataract surgery. J Refract Surg 31:791–794
Kiss HJ, Takacs AI, Kranitz K, Sandor GL, Toth G, Gilanyi B, Nagy ZZ (2016) One-day use of preoperative topical nonsteroidal anti-inflammatory drug prevents intraoperative prostaglandin level elevation during femtosecond laser-assisted cataract surgery. Curr Eye Res 41:1064–1067
Anisimova NS, Arbisser LB, Petrovski G, Petrichuk SV, Sobolev NP, Petrovski B, Borsenok SA, Komah YA, Malyugin BE (2018) Effect of NSAIDs on pupil diameter and expression of aqueous humor cytokines in FLACS versus conventional phacoemulsification. J Refract Surg 34:646–652
Bali SJ, Hodge C, Lawless M, Roberts TV, Sutton G (2012) Early experience with the femtosecond laser for cataract surgery. Ophthalmology 119:891–899
Hashemi H, Seyedian MA, Mohammadpour M (2015) Small pupil and cataract surgery. Curr Opin Ophthalmol 26:3–9
Joseph J, Wang HS (1993) Phacoemulsification with poorly dilated pupils. J Cataract Refract Surg 19:551–556
Conrad-Hengerer I, Hengerer FH, Al Juburi M, Schultz T, Dick HB (2014) Femtosecond laser-induced macular changes and anterior segment inflammation in cataract surgery. J Refract Surg 30:222–226
Levitz L, Reich J, Roberts TV, Lawless M (2015) Incidence of cystoid macular edema: femtosecond laser-assisted cataract surgery versus manual cataract surgery. J Cataract Refract Surg 41:683–686
Vane JR, Botting RM (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104:2S-8S (discussion 21S-22S)
Keulen-de Vos HC, van Rij G, Renardel de Lavalette JC, Jansen JT (1983) Effect of indomethacin in preventing surgically induced miosis. Br J Ophthalmol 67:94–96
Li Q, Luyo D, Matteson DM, Chan CC (1998) Suppressive effect of antiflammin-2 on compound 48/80-induced conjunctivitis. Role of phospholipase A2s and inducible nitric oxide synthase. Ocul Immunol Inflamm 6:65–73
McColgin AZ, Heier JS (2000) Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 11:3–6
El-Harazi SM, Feldman RM (2001) Control of intra-ocular inflammation associated with cataract surgery. Curr Opin Ophthalmol 12:4–8
Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305
Chu L, Wang B, Xu B, Dong N (2013) Aqueous cytokines as predictors of macular edema in non-diabetic patients following uncomplicated phacoemulsification cataract surgery. Mol Vis 19:2418–2425
Mesquida M, Leszczynska A, Llorenç V, Adán A (2014) Interleukin-6 blockade in ocular inflammatory diseases. Clin Exp Immunol 176:301–309
Gu R, Zhou M, Jiang C, Yu J, Xu G (2016) Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. Clin Exp Ophthalmol 44:128–134
Hernandez C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simo R (2005) Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabet Med 22:719–722
Balaiya S, Edwards J, Tillis T, Khetpal V, Chalam KV (2011) Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma. Clin Ophthalmol 5:553–556
Meacock WR, Spalton DJ, Stanford MR (2000) Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol 84:332–336
Prada J, Ngo-Tu T, Baatz H, Hartmann C, Pleyer U (2000) Detection of tumor necrosis factor alpha and interleukin 1 alpha gene expression in human lens epithelial cells. J Cataract Refract Surg 26:114–117
Ambache NP, Brummer HC (1968) A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts. Br J Pharmacol Chemother 33:162–170
Hall DW, Bonta IL (1977) Prostaglandins and ocular inflammation. Doc Ophthalmol 44:421–434
Schultz T, Joachim SC, Stellbogen M, Dick HB (2015) Prostaglandin release during femtosecond laser-assisted cataract surgery: main inducer. J Refract Surg 31:78–81
Musleh MG, Bokre D, Dahlmann-Noor AH (2020) Risk of intraocular pressure elevation after topical steroids in children and adults: a systematic review. Eur J Ophthalmol 30:856–866
Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Amento EP (1991) TGF-beta 1 accelerates wound healing: reversal of steroid-impaired healing in rats and rabbits. Growth Factors 5:295–304
Wu YT, Truong TN, Tam C, Mendoza MN, Zhu L, Evans DJ, Fleiszig SMJ (2019) Impact of topical corticosteroid pretreatment on susceptibility of the injured murine cornea to Pseudomonas aeruginosa colonization and infection. Exp Eye Res 179:1–7
Rigas B, Huang W, Honkanen R (2020) NSAID-induced corneal melt: clinical importance, pathogenesis, and risk mitigation. Surv Ophthalmol 65:1–11
Aragona P, Stilo A, Ferreri F, Mobrici M (2005) Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren’s syndrome patients. Eye (Lond) 19:535–539
Chen H, Lin H, Chen W, Zhang B, Xiang W, Li J, Chen W (2017) Topical 0.1% bromfenac sodium for intraoperative miosis prevention and prostaglandin E2 inhibition in femtosecond laser-assisted cataract surgery. J Ocul Pharmacol Ther 33:193–201
Acknowledgements
The authors thank Sae-Byeok Hwang and Soon-Suk Kang for their contribution to the data analysis.
Funding
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2020R1F1A1073627); by the Research and Business Development Program through the Korea Institute for Advancement of Technology (KIAT), funded by the Ministry of Trade, Industry and Energy (MOTIE) (grant number, P0014063); and by a grant from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (2019IP0049-1, 2020IP0045-3).
Author information
Authors and Affiliations
Contributions
JHL: study supervision, concept and study design, data collection, data interpretation, data analysis and statistics, drafting, revision and final approval of manuscript
HSC: concept and study design, data collection, data interpretation, data analysis and statistics
SYM: Data collection, data interpretation, data analysis and statistics, drafting
JY: data collection, drafting
KL: data collection, drafting
HL: data collection, data analysis and statistics
JYK: study supervision, revision and final approval of manuscript
HTL: study supervision, revision and final approval of manuscript
HT: study supervision, concept and study design, data interpretation, revision and final approval of manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study adhered to the tenets of the Declaration of Helsinki. The study protocol was approved by the Ethics Committee of Asan Medical Center (Seoul, Republic of Korea).
Consent to participate
Written informed consent forms were signed by all study participants prior to the procedure.
Consent for publication
Written informed consent forms for publication of the research were signed by all study participants prior to the procedure.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, J.H., Chung, H.S., Moon, S.Y. et al. Effect of preoperative eyedrops on cytokine concentrations in aqueous humor of patients undergoing femtosecond laser–assisted cataract surgery. Graefes Arch Clin Exp Ophthalmol 260, 885–891 (2022). https://doi.org/10.1007/s00417-021-05428-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05428-1